When.com Web Search

  1. Ads

    related to: is vimpat better than keppra for dogs cost

Search results

  1. Results From The WOW.Com Content Network
  2. Lacosamide - Wikipedia

    en.wikipedia.org/wiki/Lacosamide

    Lacosamide, sold under the brand name Vimpat among others, is a medication used for the treatment of partial-onset seizures and primary generalized tonic-clonic seizures. [2] It is used by mouth or intravenously .

  3. Anticonvulsant - Wikipedia

    en.wikipedia.org/wiki/Anticonvulsant

    The vagus nerve stimulator is a device that can be implanted into patients with epilepsy, especially that which originates from a specific part of the brain. However, both of these treatment options can cause severe adverse effects. Additionally, while seizure frequency typically decreases, they often do not stop entirely. [40] [41]

  4. Levetiracetam - Wikipedia

    en.wikipedia.org/wiki/Levetiracetam

    Levetiracetam, sold under the brand name Keppra among others, is a novel antiepileptic drug [7] used to treat epilepsy. [8] It is used for partial-onset , myoclonic , or tonic–clonic seizures, [ 7 ] and is taken either by mouth as an immediate or extended release formulation or by injection into a vein .

  5. Average Cost of Pet Insurance in 2024 For Cats & Dogs - AOL

    www.aol.com/lifestyle/average-cost-pet-insurance...

    Your dog accidentally ingests chocolate and needs emergency treatment costing $2,000. Without insurance, you'd pay the full $2,000. With insurance, here's how it breaks down:

  6. How much are those dogs in the dog show? What 20 top breeds cost

    www.aol.com/finance/2018-02-09-how-much-are...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Seletracetam - Wikipedia

    en.wikipedia.org/wiki/Seletracetam

    Seletracetam (UCB 44212) is a pyrrolidone-derived [2] drug of the racetam family that is structurally related to levetiracetam (trade name Keppra). [ 2 ] [ 3 ] It was under development by UCB Pharmaceuticals as a more potent and effective anticonvulsant drug to replace levetiracetam but its development has been halted.